In the clinical context, CK19+ HCC is highly invasive and resistant to chemoradiotherapy and shows high rates of lymph node metastasis and early recurrence after hepatic resection or liver transplantation (9–11). Here, KRT19 is linked to hepatocellular carcinoma.